Lift & Co. (TSXV:LIFT,OTCQB:LFCOF) issued its financial and operational results for Q4 and fiscal 2019.

As quoted in the press release:


The Company is pleased to report another fiscal year of triple-digit revenue growth. Revenues grew 150 percent to C$5.8 million for the year and grew 130 percent to C$2.5 million for the quarter. The revenue increase for the year is the result of growth across all of the Company’s revenue streams.

“We are pleased with the momentum that we’re seeing across the Company for all platform products,” said Matei Olaru, CEO of Lift & Co. “We experienced a year of triple-digit revenue growth and have achieved numerous milestones during our first seven months as a publicly traded company. Most importantly, we are seeing returns from our strategy to develop a platform of digital marketing products that both generate revenue and double down as data mousetraps. It is our belief that in addition to the revenue it generates, the data we gather through our website lift.co creates a differentiated data product for the emerging cannabis-CPG industry by combining cannabis consumer behavioural and transactional data, differentiating us from cannabis data peers.”

FISCAL YEAR 2019 FINANCIAL HIGHLIGHTS

  • Revenues for the year ended March 31,2019 increased by $3.5 million, an increase of 150 percent compared to the prior fiscal year
  • Event Marketing revenues increased by $2.8 million, an increase of 134 percent compared to the prior fiscal year
  • Net loss for the twelve months ended March 31, 2019 was $7,956,982 compared to a net loss of C$5,987,399 for the same period in 2018

Click here to read the full press release.

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less